TTM
$22.99B
YoY change
-17.9%
5Y CAGR
-1.8%
Peak year (1999)
$38.41B
Cumulative EBITDA
$439.56B
EBITDA history chart for UnitedHealth Group (UNH) from 1985 to 2025
Latest: $23.06B
EBITDA growth chart for UnitedHealth Group (UNH) from 1985 to 2025
Latest: -17.9%
EBITDA history table for UnitedHealth Group (UNH) from 1985 to 2025
| 2025 | $23.06B | -17.9% | −$5.02B | ||
| 2024 | $28.08B | -22.7% | −$8.25B | ||
| 2023 | $36.33B | +14.1% | +$4.50B | ||
| 2022 | $31.84B | +17.6% | +$4.76B | ||
| 2021 | $27.07B | +7.0% | +$1.78B | ||
| 2020 | $25.30B | +12.9% | +$2.89B | ||
| 2019 | $22.41B | +13.3% | +$2.63B | ||
| 2018 | $19.77B | +13.3% | +$2.32B | ||
| 2017 | $17.45B | +16.5% | +$2.47B | ||
| 2016 | $14.98B | +17.9% | +$2.27B | ||
| 2015 | $12.71B | +8.2% | +$962.00M | ||
| 2014 | $11.75B | +6.9% | +$754.00M | ||
| 2013 | $11.00B | +4.1% | +$435.00M | ||
| 2012 | $10.56B | +10.2% | +$975.00M | ||
| 2011 | $9.59B | +7.4% | +$660.00M | ||
| 2010 | $8.93B | +21.5% | +$1.58B | ||
| 2009 | $7.35B | +17.7% | +$1.11B | ||
| 2008 | $6.24B | -27.8% | −$2.40B | ||
| 2007 | $8.64B | +12.9% | +$991.00M | ||
| 2006 | $7.65B | +38.3% | +$2.12B | ||
| 2005 | $5.53B | +23.6% | +$1.06B | ||
| 2004 | $4.47B | -85.1% | −$25.52B | ||
| 2003 | $30.00B | +1128.8% | +$27.55B | ||
| 2002 | $2.44B | +33.3% | +$610.00M | ||
| 2001 | $1.83B | +26.5% | +$384.00M | ||
| 2000 | $1.45B | -96.2% | −$36.97B | ||
| 1999 | $38.41B | +4325.6% | +$37.55B | ||
| 1998 | $868.00M | -2.3% | −$20.00M | ||
| 1997 | $888.00M | +19.3% | +$143.46M | ||
| 1996 | $744.54M | +5.0% | +$35.51M | ||
| 1995 | $709.04M | +17.0% | +$102.97M | ||
| 1994 | $606.07M | +70.2% | +$249.97M | ||
| 1993 | $356.10M | +70.5% | +$147.30M | ||
| 1992 | $208.80M | +61.4% | +$79.40M | ||
| 1991 | $129.40M | +96.4% | +$63.50M | ||
| 1990 | $65.90M | +95.5% | +$32.20M | ||
| 1989 | $33.70M | +5516.7% | +$33.10M | ||
| 1988 | $600.00K | -104.7% | +$13.50M | ||
| 1987 | −$12.90M | -209.3% | −$24.70M | ||
| 1986 | $11.80M | +107.0% | +$6.10M | ||
| 1985 | $5.70M | — | — |
- 2025$23.06B-17.9%
- 2024$28.08B-22.7%
- 2023$36.33B+14.1%
- 2022$31.84B+17.6%
- 2021$27.07B+7.0%
- 2020$25.30B+12.9%
- 2019$22.41B+13.3%
- 2018$19.77B+13.3%
- 2017$17.45B+16.5%
- 2016$14.98B+17.9%
- 2015$12.71B+8.2%
- 2014$11.75B+6.9%
- 2013$11.00B+4.1%
- 2012$10.56B+10.2%
- 2011$9.59B+7.4%
- 2010$8.93B+21.5%
- 2009$7.35B+17.7%
- 2008$6.24B-27.8%
- 2007$8.64B+12.9%
- 2006$7.65B+38.3%
- 2005$5.53B+23.6%
- 2004$4.47B-85.1%
- 2003$30.00B+1128.8%
- 2002$2.44B+33.3%
- 2001$1.83B+26.5%
- 2000$1.45B-96.2%
- 1999$38.41B+4325.6%
- 1998$868.00M-2.3%
- 1997$888.00M+19.3%
- 1996$744.54M+5.0%
- 1995$709.04M+17.0%
- 1994$606.07M+70.2%
- 1993$356.10M+70.5%
- 1992$208.80M+61.4%
- 1991$129.40M+96.4%
- 1990$65.90M+95.5%
- 1989$33.70M+5516.7%
- 1988$600.00K-104.7%
- 1987−$12.90M-209.3%
- 1986$11.80M+107.0%
- 1985$5.70M—
EBITDA values are taken from UnitedHealth Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at UnitedHealth Group (UNH)
According to UnitedHealth Group's latest reported financial statements, the company's current EBITDA (TTM) is $22.99B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual EBITDA for UnitedHealth Group (UNH) came in at $23.06B – declined 17.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, UnitedHealth Group EBITDA compounded at -1.8% per year, with a net decline across the window.
Between 1999 and 2025, UnitedHealth Group EBITDA plunged 40.0%, falling from $38.41B to $23.06B.
The record annual EBITDA stands at $38.41B, reached in 1999; the historical low of −$12.90M was recorded in 1987.
UnitedHealth Group EBITDA by Year
UnitedHealth Group EBITDA 2025: $23.06B
UnitedHealth Group EBITDA in 2025 was $23.06B, declined 17.9% below 2024.
UnitedHealth Group EBITDA 2024: $28.08B
2024's EBITDA for UnitedHealth Group came in at $28.08B, declined 22.7% below 2023.
UnitedHealth Group EBITDA 2023: $36.33B
UnitedHealth Group posted EBITDA of $36.33B in 2023, grew 14.1% from 2022.
UnitedHealth Group EBITDA 2022: $31.84B
In 2022, UnitedHealth Group reported EBITDA of $31.84B, grew 17.6% from 2021.
UnitedHealth Group EBITDA 2021: $27.07B
UnitedHealth Group EBITDA in 2021 was $27.07B.
See more financial history for UnitedHealth Group (UNH).
Sector peers by EBITDA
Healthcare peers of UnitedHealth Group (UNH), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $19.83B | |
| $17.63B | |
| $16.90B | |
| $11.47B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
UnitedHealth Group (UNH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation